Among the many options for a treatment strategy - combinations of radiation therapy, surgical treatment or chemotherapy - the right choice is needed, which is not always possible for one specialist, which is why a multidisciplinary, or team, approach to the treatment of oncological diseases is correct in modern practice. To this end, the K+31 West clinic has implemented the possibility of holding an oncological consultation, where, in the course of a collective discussion by doctors of various specialties, the diagnosis is clarified or corrected and the most effective individual treatment plan is drawn up.
The board usually consists of:
Experts from related specialties may be involved in the council.
In the clinic, targeted, immuno- and chemotherapy is carried out for patients with tumors of various localizations:
Chemotherapy is carried out according to regulated protocols according to world recommendations. A personal treatment regimen is drawn up for each patient, taking into account the individual characteristics of the patient and the oncological disease. Chemotherapy is also carried out for patients who come from other countries with an already prescribed treatment regimen. This treatment can be carried out in a hospital setting.
If necessary, in the case of a serious condition of the patient, detoxification treatment is first carried out before chemotherapy to improve his condition.
The department of oncology also pays special attention to preventive work, the essence of which is to identify benign, potentially dangerous, precancerous diseases, as well as malignant tumors in those patients of the clinic who are treated in other departments or are consulted by other specialists.
This is realized thanks to the close cooperation of oncologists with specialists from other profiles of K+31 clinics.
The clinic "K+31 West" provides treatment according to compulsory medical insurance in the following areas: radiation therapy, chemoradiotherapy for all nosologies without restrictions in the form 057/y. You can sign up for the clinic under compulsory medical insurance from all regions, including Moscow, except for Dagestan, Tambov, Volgograd and the Moscow region.
Clinical trial for glioma patients
In the medical center K+31 West*, located at the address: Moscow, st. Orshanskaya, 16, a clinical study is being conducted for patients with histologically verified Grade I-IV glioma, using the investigational drug "RadioMedFluorTyrosine" (Fluoroethyltyrosine [18F]), which is used in PET-CT diagnostics of brain tumors. The new clinical trial will be a multicentre, prospective, randomized, open-label, comparative study to investigate the diagnostic efficacy, safety, and patient tolerability of the radiopharmaceutical.
Breast cancer: broadcast with Elena Fedorovna Satirova
Satirova Elena Fedorovna, head of the antitumor drug treatment department of the K+31 West clinic, oncologist of the highest category, on April 14, gave an online lecture on the possibilities of treating breast cancer and the features of hormonal therapy.
Radiation therapy: world problems according to the IAEA
IAEA studies have found significant shortcomings in the provision of radiotherapy care - the treatment of cancer in children. The results showed that the existing gaps are global in scope. The study also identified ways to improve clinical practice.
Systemic review and meta-analysis of local salvage therapy after EBRT for prostate cancer (MASTER study)
The management of locally recurrent prostate cancer after radical radiotherapy remains controversial due to the perceived high incidence of severe genitourinary (GU) and gastrointestinal (GI) toxicity associated with any method of salvage radiotherapy.
Being overweight increases the risk of developing cancer
The link between obesity in adulthood and an increased risk of cancer has already been known, but the risk associated with overweight in childhood and puberty has not previously been described in detail.
Our doctor in your city
As part of expanding the network of assistance throughout the country, our experts made their first working trip to Ingushetia.
New possibilities for the treatment of oncopathologies
Sotorasib has been shown to be effective in the treatment of colorectal cancer and pancreatic cancer with the KRAS G12C mutation in early clinical trials.
Influence of interruptions in radiation therapy courses on long-term results of treatment
Modern radiotherapy does not accept breaks in treatment. The loss of local control for every unplanned missed day of treatment is beyond doubt. However, the reality is that radiation oncologists are increasingly faced with the need to stop a radical course of radiation or chemoradiotherapy, for example, due to infection of a patient with COVID-19.
Should meat be excluded for cancer patients?
The consumption of red meat by patients with stage III colon cancer does not increase the risk of recurrence and does not reduce overall life expectancy.
When should you stop cancer treatment?
An interesting article was published on the rosoncoweb website in the format of a discussion scene "When the end is near: to be treated in order to live - or to live in order to be treated?". Two well-known representatives of the medical community collided in it: doctors of medical sciences, professors Zhukov Nikolai Vladimirovich and Mitin Timur.
Changes in clinical guidelines. Radiation therapy
In January 2022, the National Cancer Network (NCCN) made a number of significant additions to the recommendations for radiation therapy for rectal cancer, which are important not only for specialists, but also for patients.
The use of aspirin in breast cancer
The use of aspirin after combined treatment of early breast cancer does not reduce the likelihood of recurrence.
Allergy medications to reduce cancer risk?
The researchers concluded that the use of antihistamines may reduce the risk of developing hepatocellular carcinoma in patients with viral hepatitis B and C, but further research is needed.
|Прием (осмотр, консультация) врача-онколога первичный||from 4 000.00|
|Осмотр (консультация) врачом-радиотерапевтом первичный||from 5 400.00|
|Консилиум (онкологический)||from 16 000.00|
|Консилиум расширенный (онкологический)||from 45 000.00|